- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Corporate and Securities Litigation
- E-Discovery
- Global Construction and Infrastructure Disputes
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
News 42 results
Cases & Deals
Cases & Deals
June 7, 2026
King & Spalding Secures Significant Summary Judgment Victory for Boehringer Ingelheim in Zantac-Related Litigation
Cases & Deals
April 13, 2026
King & Spalding Secures Significant Win Dismissing 40,000+ Cases for Boehringer Ingelheim in Zantac-Related Litigation in Delaware
Cases & Deals
March 5, 2026
Sage Completes $65 Million Series C Financing
Cases & Deals
February 27, 2026
Appeals Court Rejects Kaiser Health Plan’s Attempt to Throw Out $105 Million Judgment
Cases & Deals
January 27, 2026
King & Spalding Secures Significant Success for R.J. Reynolds
Cases & Deals
November 25, 2025
King & Spalding Secures Another Victory for Boehringer Ingelheim in Zantac-Related Trial
Cases & Deals
October 10, 2025
King & Spalding Secures Significant Victory for R.J. Reynolds
Cases & Deals
August 28, 2025
King & Spalding Secures Another Victory for Boehringer Ingelheim in Zantac-Related Trial
Cases & Deals
Cases & Deals
July 8, 2025
King & Spalding Secures Another Victory for Boehringer Ingelheim in Zantac-Related Trial
Cases & Deals
July 7, 2025
King & Spalding Is Representing Northlane Capital Partners in the Sale of The Difference Card